Logo

Lion s Revenues Tank, Losses Narrow in Q4 of FY2003/2004

May 04, 2004

NEW YORK, May 4 (GenomeWeb News) - Lion Bioscience revenues took a nosedive, while its losses narrowed during its fourth quarter of fiscal year 2003/2004, which ended March 31. The company reported preliminary results for the quarter today.

 

Lion's revenues plummeted to €3.1 million ($3.7 million), from €9 million ($10.9 million) during the same quarter a year ago.

 

The company's net loss totaled €4.9 million, down from €18.5 million during the same period last year.

 

As of March 31, Lion had €43.1 million in cash and cash equivalents.

Breaking News
The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.